Auteur HEP-CORE STUDY GROUP

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Nouveauté

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses [Viewpoint]

J. V. LAZARUS ; K. SAFREED-HARMON ; S. R. STUMO ; M. JAUFFRET-ROUSTIDE ; M. MATICIC ; T. REIC ; E. SCHATZ ; J. TALLADA ; M. HARRIS ; HEP-CORE STUDY GROUP | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of achieving an 80% reduction in new infections and a 65% reduction in deaths from hepatit[...]

Plus d'info

Ajouter à la sélection